HOLX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Hologic Inc (HOLX) is not a strong buy at the moment for a beginner investor with a long-term focus. While the technical indicators show some bullish trends, the lack of significant positive catalysts, declining financial performance in key metrics like net income and EPS, and a recent analyst downgrade suggest a cautious approach. The stock may be better suited for monitoring rather than immediate investment.
The technical indicators show mixed signals. The MACD is positive but contracting, RSI is neutral at 51.046, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot point of 75.198, with resistance at 75.427 and support at 74.968.
Hedge funds are significantly increasing their buying activity, with a 4616.24% increase in the last quarter. Gross margin improved by 1.53% YoY.
Net income dropped by -10.90% YoY, and EPS declined by -9.20% YoY in the latest quarter. Analysts have downgraded the stock recently, with a reduced price target. No recent news or congress trading activity to act as a catalyst.
In Q1 2026, revenue increased by 2.54% YoY to $1.048 billion, but net income dropped to $179.1 million (-10.90% YoY), and EPS fell to 0.79 (-9.20% YoY). Gross margin improved slightly to 57.21% (+1.53% YoY).
Evercore ISI downgraded Hologic to In Line from Outperform, with a reduced price target of $78 (down from $79).
